Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expectative versus early treatment for patent ductus arteriosus in extremely preterm infants
NL-OMON21314Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of indomethacin and ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Primary composite endpoint. Planned start Jul 2016; status: not yet recruiting.
02
Drugs
indomethacinibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NL-OMON21314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21314.